PNC Financial Services Group
ATYR

PNC Financial Services Group’s aTyr Pharma ATYR Stock Holding History

PNC Financial Services Group’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$762 Sell
1,276
-6,920
-84% -$4.52K ﹤0.01% 4895
2026
Q1 		$6.39K Buy
8,196
+7,718
+1,615% +$6.52K ﹤0.01% 4158
2025
Q4 		$374 Sell
478
-333
-41% -$273 ﹤0.01% 4895
2025
Q3 		$585 Buy
+811
New +$3.67K ﹤0.01% 4776

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PNC Financial Services Group's ATYR Position: Q2 2026 in Review

PNC Financial Services Group reduced its aTyr Pharma (ATYR) stake by 84% in Q2 2026, selling an estimated $4.52K and leaving 1,276 shares worth $762. The position accounts for ﹤0.01% of the portfolio, ranked #4895.

PNC Financial Services Group first reported a position in ATYR in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.39K in Q1 2026. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • PNC Financial Services Group held 1,276 shares of aTyr Pharma worth $762 as of Q2 2026.
  • PNC Financial Services Group sold 6,920 aTyr Pharma shares in Q2 2026, an estimated $4.52K.
  • aTyr Pharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4895 holding.
  • PNC Financial Services Group first reported a position in aTyr Pharma in Q3 2025 and has held it in 4 quarters since.
  • PNC Financial Services Group's aTyr Pharma position peaked at $6.39K in Q1 2026.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.